SV Health Investors beats target for dementia-focused fund

The fund’s strategic and impact-oriented LPs include big pharma names such as Pfizer, Bristol Myers Squibb, AARP and Alzheimer’s Research UK, which are excited by improved scientific understanding of dementia that promise to increase clinical trial successes.

FundraisingInvestorsManagersEuropeNorth AmericaUKUSWestern EuropeFundraisingHealthcareTechnology